Raizada A, Dwivedi S, Bhattacharya S
Department of Medicine, University College of Medical Sciences, University of Delhi, and GTB Hospital, Delhi, India.
Trop Doct. 2011 Jul;41(3):154-6. doi: 10.1258/td.2011.100440. Epub 2011 May 17.
With an estimated 5.7 million people living with HIV/AIDS, India has the highest HIV/AIDS prevalence in the world, according to UNAIDS. Due to similar routes of transmission, co-infection of HIV with hepatitis B and hepatitis C viruses is a common event with significant clinical implications. The present study was undertaken to highlight the profile of patients of HIV with HBV/HCV co-infection, as literature from India on this topic is sparse. Out of 1953 patients suffering from HIV registered at our centre during the study period, 80 patients were co-infected with HBV/HCV. HBV co-infection was detected in 2.61% of patients and HCV co-infection in 1.69% of subjects. Our study demonstrates low HIV /HCV/HBV co-infection rates in Delhi as compared to most other studies from India, which is partly attributable to low incidence of intravenous drug use and infrequent transfusion-related infections in our study group.
据联合国艾滋病规划署称，印度估计有570万人感染艾滋病毒/艾滋病，是全球艾滋病毒/艾滋病感染率最高的国家。由于传播途径相似，艾滋病毒与乙型肝炎和丙型肝炎病毒合并感染是常见情况，具有重大临床意义。由于印度关于这一主题的文献稀少，本研究旨在突出艾滋病毒合并乙肝/丙肝感染患者的概况。在研究期间，我们中心登记的1953名艾滋病毒患者中，有80名患者合并感染了乙肝/丙肝。2.61%的患者检测出乙肝合并感染，1.69%的受试者检测出丙肝合并感染。我们的研究表明，与印度其他大多数研究相比，德里的艾滋病毒/丙肝/乙肝合并感染率较低，这部分归因于我们研究组中静脉吸毒发生率低以及输血相关感染不常见。
